Switch View
© BusinessWire
14.10.2025
ISIN: US98401F1057
Xencor Inc
XNCR
LISTED
NASDAQ
Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced the upcoming presentation of initial results from the ongoing Phase 1 dose-escalation study of XmAb819, a bispecific ENPP3 x CD3 T-cell engaging bispecific antibody, in patient...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
Op de AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics kondigt Merus de publicatie aan van het abstract over petosemtamab in gemetastaseerde colorectale kanker
News Preview
- In combinatie met FOLFOX/FOLFIRI (1L en 2L mCRC) en als monotherapie (3L+ mCRC) toont petosemtamab werkzaamheid tegen tumoren en een beheerbaar veiligheidsprofiel aan...
Themefolio
Profiler
Peergroup
© ActuNews
14.10.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIALIZATION OF TX01
News Preview
THX PHARMA (THERANEXUS) AND EXELTIS ACHIEVE KEY MILESTONE TOWARDS THE COMMERCIALIZATION OF TX01
THX Pharma (Theranexus) and Exeltis have reached a pivotal milestone, setting the stage for the regulatory submission of TX01 for Gaucher and Niemann-Pick type C diseases
Lyon, France – Madrid, Spain – October 14, 2025 – 6.30pm CEST &nd...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© ActuNews
14.10.2025
ISIN: FR0013286259
Theranexus SA
ALTHX
LISTED
EURONEXT
THX PHARMA (THERANEXUS) ET EXELTIS FRANCHISSENT UNE ÉTAPE MAJEURE VERS LA COMMERCIALISATION DE TX01
News Preview
THX PHARMA (THERANEXUS) ET EXELTIS FRANCHISSENT UNE ÉTAPE MAJEURE VERS LA COMMERCIALISATION DE TX01
THX Pharma (Theranexus) et Exeltis ont atteint une étape clé, ouvrant la voie au dépôt du dossier réglementaire de TX01 pour les maladies de Gaucher et de Niemann-Pick de type C
Lyon, France – Madrid, Es...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
14.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman
News Preview
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) saw the price of their shares crater $55.75, or about 90%, after the company announced disastrous VELA-2 trial results for sonelokimab, its highly anticipated treatment for patients with skin disease (hidradenitis...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against aTyr Pharma, Inc. ("aTyr" or "the Company") (NASDAQ: ATYR) and certain of its officers....
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: US4222172086
Hear AtLast Holdings, Inc.
HRAL
LISTED
OTC
Hear At Last Launches HOHM Token for Capital Raise on Solana Blockchain - Now Ready to Trade
News Preview
Miami, Florida--(Newsfile Corp. - October 14, 2025) - Hear At Last (OTCID: HRAL), a trailblazer in innovative housing solutions, is thrilled to announce the successful launch of its cryptocurrency token, HOHM, on the Solana blockchain. The HOHM token is now live and ready to trade, marking a pivotal step in HRAL's mission to revolutionize affordabl...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Shareholder Alert: The Ademi Firm investigates whether Astria Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
News Preview
MILWAUKEE, Oct. 14, 2025 /PRNewswire/ -- The Ademi Firm is investigating Astria (NASDAQ: ATXS) for possible breaches of fiduciary duty and other violations of law in its transaction with BioCryst....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: FR0000120578
Sanofi SA
SAN
LISTED
EURONEXT
Sanofi: Information concerning the total number of voting rights and shares - September 2025
News Preview
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LFMD 13-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
News Preview
LFMD Investors with Losses Encouraged to Contact the Firm Before Oct. 27th Deadline
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided invest...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US0367521038
Elevance Health Inc
ANTM
LISTED
NYSE
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit
News Preview
SAN DIEGO, Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV) shares....
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva AI Agents to Be Released Across All Veeva Applications
News Preview
Deep, industry-specific agents planned for availability starting this December
PLEASANTON, Calif., Oct. 14, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI Agents are planned for availability starting December 2025 for commercial and acr...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
14.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva AI Agents to Be Released Across All Veeva Applications
News Preview
Deep, industry-specific agents planned for availability starting this December
PLEASANTON, Calif., Oct. 14, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI Agents are planned for availability starting December 2025 for commercial and acr...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: FR0000032526
Guerbet SA
GBT
LISTED
EURONEXT
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2025
News Preview
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 septembre 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: AU0000165375
Clarity Pharmaceuticals Ltd
CU6
LISTED
ASX
Co-PSMA trial achieves primary endpoint
News Preview
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT06907641)[1] Inve...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: KR7328130000
Lunit Inc.
328130
LISTED
KOE
Lunit AI Predicts Immunotherapy Outcome in Colorectal, Kidney, and Lung Cancer at ESMO 2025
News Preview
AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, advanced ccRCC, and NSCLC with data featured in both oral and poster presentations
SEOUL, South Korea, Oct. 14, 2025 /PRNewsw...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US01625V1044
Alignment Healthcare Inc
ALHC
LISTED
NASDAQ
Alignment Health Plan and Intermountain Health Launch $0-Premium, 5-star Medicare Advantage Plan for Nevada Seniors
News Preview
New co-branded HMO expands access to high-quality, affordable care in Clark County, adding second 5-star plan for Alignment in the state New co-branded HMO expands access to high-quality, affordable care in Clark County, adding second 5-star plan for Alignment in the state...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CA40390B1094
HLS Therapeutics Inc
HLS
LISTED
TSX
HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
News Preview
TORONTO, Oct. 14, 2025 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease, in collaboration with its partner, Amarin Corporation plc (NASDAQ: AMRN) announce the presenta...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
News Preview
Red Light Holland granted Second DEA Import Permit through Irvine Labs for expanded psilocybin research programThis United States Controlled Substances Permit, authorizes a significantly larger shipment of psilocybin truffles, from Red Light Holland's Netherlands facility, for continued R&DToronto, Ontario--(Newsfile Corp. - October 14, 2025) -...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Premier, Inc. to Report Fiscal 2026 First Quarter Results on November 4, 2025
News Preview
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2026 first quarter on Tuesday, November 4, 2025, at approximately 6:30 a.m. ET.
As a result of the company’s pending acquisition by Patient Square Capital, Premier will not host a conference call to discuss its financial results.
About Premier, I...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
ATXS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Astria Therapeutics, Inc. Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Astria Therapeutics, Inc. (NASDAQ: ATXS) to BioCryst Pharmaceuticals, Inc. for $8.55 in cash per share and 0.59 shares of BioCryst common stock per share of Astria is fair to Astria shareholders.
Halper Sadeh encourages Astria shareholders to click here to learn...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma, Inc.'s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
News Preview
ATYR Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, Oct. 14, 2025 /PRNewswire/ -- A federal class-action lawsuit has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) following a devastating 83% drop in the biotech company's stock price after its lead drug candidate fai...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US8636671013
Stryker Corp
SYK
LISTED
NYSE
Stryker to Feature Expanding Trauma Portfolio at the Orthopaedic Trauma Association Annual Meeting 2025
News Preview
Stryker (NYSE:SYK), a global leader in medical technologies, will showcase new additions to its trauma offerings at the Orthopaedic Trauma Association (OTA) Annual Meeting, October 15–18, in Phoenix, Ariz. (booth #601). The company will highlight upcoming expansions to its nailing and plating platforms.
For more than 80 years, Stryker has collab...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare launches CareIntellect for Perinatal, a cloud-first application to optimize care delivery and help send families home healthy
News Preview
GE HealthCare (Nasdaq: GEHC) today announced the launch of CareIntellect™ for Perinatal2, a cloud-first Software-as-a-Service (SaaS) application designed to deliver clear, actionable insights that help clinicians improve maternal and fetal care.3 CareIntellect for Perinatal supports clinicians by integrating information from disparate clinical sou...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process
News Preview
VANCOUVER, BC and MADISON, Wis., Oct. 14, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to announce that results from a collaborative research project conducted in the Bavarian Forest National Park in Germany have recen...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process
News Preview
VANCOUVER, BC and MADISON, Wis., Oct. 14, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to announce that results from a collaborative research project conducted in the Bavarian Forest National Park in Germany have recently bee...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health® 2025 Rx Report highlights transformation of community pharmacy to meet patient needs
News Preview
CVS Health/Morning Consult survey reveals patients trust and prefer local pharmacy care, want expanded services in community pharmacy
Number of pharmacy technicians who want to become pharmacists has increased significantly since 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs Notes Publication of Mia Femtech 3-Year Prospective Study Results in Aesthetic Surgery Journal
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the publication of “The 3-Year Results of a 100-Patient Prospective Study of Safety and Effectiveness of Mia Femtech” in the Aesthetic Surgery Journal....
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Dr. Mimi Lee, MD, PhD, as Chief Precision Medicine Officer. Dr. Lee will spearhead GeneDx’s vision to unlock the power of genomics to help every person live their healthiest life.
As Chief Precision Medicine Officer, Dr. Lee will lead...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2025 financial results on Wednesday, November 5th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 5th, at 9:00 a.m. ET.
Investors will have the opportunity to listen to a live webcast of the conf...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US68218J1034
OmniAb Inc
OABI
LISTED
NASDAQ
OmniAb to Report Third Quarter 2025 Financial Results on November 4
News Preview
OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2025, after the close of the U.S. financial markets on Tuesday, November 4, 2025, and will hold a conference call that same day beginning at 4:30 p.m. Eastern time.
Conference Call and Webcast Information
What:
OmniAb con...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
Humana Foundation Expands National Efforts to Improve Seniors’ Emotional Health
News Preview
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced its ambition to become a national leader in addressing seniors’ emotional health. More than one in four seniors (29%) report being socially isolated, increasing their risk of dementia (by 50%) and self-harm. The Foundation’s 2025 program...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US2183521028
Corcept Therapeutics Inc
CORT
LISTED
NASDAQ
Corcept Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
News Preview
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, has submitted a Marketing Authorization Application (MAA) to the European Medicines Age...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US7140461093
Revvity Inc
RVTY
LISTED
NYSE
Revvity Showcases Progress with Purpose in 2025 Impact Report
News Preview
Revvity, Inc. (NYSE: RVTY) today released its annual Impact Report, a comprehensive reflection of the Company’s sustainability, social and governance strategy, initiatives and performance. This year’s report, Progress with Purpose: Science and Sustainability, highlights the Company’s strengthened partnerships, product innovation, sustainability dr...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf Upsizes Revolving Credit Facility to $100 Million with Needham Bank
News Preview
Represents the largest revolving credit facility in the U.S. cannabis sector to date
Landmark financing marks a significant step forward for institutional lending in cannabis
STAMFORD, Conn., Oct. 14, 2025 /CN...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CA23126M1023
Curaleaf Holdings Inc
CURA
LISTED
TSX
Curaleaf Upsizes Revolving Credit Facility to $100 Million with Needham Bank
News Preview
Represents the largest revolving credit facility in the U.S. cannabis sector to date
Landmark financing marks a significant step forward for institutional lending in cannabis
STAMFORD, Conn., Oct. 14, 2025 /PR...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: CA92663R1055
Viemed Healthcare Inc
VMD
LISTED
NASDAQ
Viemed Healthcare, Inc. to Present at the LD Micro Main Event XIX
News Preview
Presentation on Tuesday, October 21st at 11:00 AM PTLafayette, Louisiana--(Newsfile Corp. - October 14, 2025) - Viemed Healthcare, Inc. (NASDAQ: VMD), a national leader of in-home, technology-enabled post-acute respiratory care, announced today that it will be presenting at the 19th annual Main Event on Tuesday, October 21st at 11:00 AM PT at the H...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CA16106R1091
Charlotte's Web Holdings Inc
CWEB
LISTED
TSX
Charlotte's Web™ Expands its Brightside Line with Launch of Knockout Hemp THC Sleep Gummies
News Preview
The fourth addition to its
hemp-derived
THC product lineup, Knockout expands Charlotte's Web's Brightside collection into the sleep market by combining cannabinoids, clean ingredients, and fast-acting delivery technology to support quality sleep....
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: CA16106R1091
Charlotte's Web Holdings Inc
CWEB
LISTED
TSX
Charlotte's Web™ Expands its Brightside Line with Launch of Knockout Hemp THC Sleep Gummies
News Preview
The fourth addition to its
hemp-derived
THC product lineup, Knockout expands Charlotte's Web's Brightside collection into the sleep market by combining cannabinoids, clean ingredients, and fast-acting delivery technology to support quality sleep....
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US64049M2098
Neogenomics Inc
NEO
LISTED
NASDAQ
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
News Preview
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the presentation of assay-relevant data, including interventional therapy trials in progress, to showcase how its molecular residual disease (MRD) assay may benefit pharmaceutical partners at the European Society for...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US04216R1023
Armata Pharmaceuticals, Inc.
ARMP
LISTED
XASE
Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025™
News Preview
LOS ANGELES, Oct. 14, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: US38942Q2021
CalciMedica Inc
CALC
LISTED
NASDAQ
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™
News Preview
AI tools will allow CalciMedica to analyze Phase 2 datasets to refine the target patient populations and efficacy endpoints for upcoming pivotal trials
LA JOLLA, Calif., Oct. 14, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CAL...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US68752M1080
Orthofix Medical Inc
OFIX
LISTED
NASDAQ
Orthofix to Report Third Quarter 2025 Financial Results
News Preview
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day.
Interested parties may access...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: CA1380357048
Canopy Growth Corp
CGC
LISTED
NASDAQ
Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders
News Preview
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025 and adjourned to, and rec...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
News Preview
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that the companies have entered into a definitive agreement under which BioCryst has agreed to acquire Astria, a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, for a mix of cash...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US3773221029
Glaukos Corp
GKOS
LISTED
NYSE
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, bein...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial
News Preview
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line combination therapy with the tyrosine kinase inhibitor TUKYSA® (tucatinib) in patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC). HER2CLIMB-05 is evaluating TUKYSA versus placebo, bo...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze
News Preview
– Parties enter into Restructuring Support Agreement; Vireo to bid to acquire control of Schwazze assets –...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
News Preview
The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY® during Q4 This Year...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
News Preview
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
News Preview
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2025 of $1.30 per share on the company’s common stock. The dividend is payable on December 9, 2025 to shareholders of record at the close of business on November 25, 2025. The ex-dividend date is November 25, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
News Preview
Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the Company’s intent to separate its Orthopaedics business to enhance the strategic and operational focus of each company and drive value for stakeholders.
The intended separation would further strengthen the focus of Johnson & Johnson as an innovation powerhouse, serving area...
Themefolio
Profiler
Peergroup
© BusinessWire
14.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
News Preview
Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2025. “Johnson & Johnson delivered another strong performance in the third quarter fueled by the depth and strength of our portfolio and significant progress across our pipeline,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson & Johnson. “With a...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.
News Preview
NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that it has entered into a five-year, $130 million term loan facility with Trinity...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
News Preview
NEEDHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced encouraging interim data from its ongoing phase 1b clinical trial of CAN-3110 (lin...
Themefolio
Profiler
Peergroup
© PR Newswire
14.10.2025
ISIN: KYG8807B1068
Theravance Biopharma Inc
TBPH
LISTED
NASDAQ
Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting
News Preview
A retrospective cohort study of claims data demonstrated that following hospital discharge, patients adherent to YUPELRI experienced significantly fewer, and less severe, exacerbations and had significantly lower healthcare costs than non-adherent patients
Post-hoc analyses of a Phase 3 safety s...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US87427V1035
Talkspace Inc
TALK
LISTED
NASDAQ
Talkspace to Report Third Quarter 2025 Results and Host Conference Call
News Preview
NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Talkspace (Nasdaq: TALK), a leading online behavioral health care company, today announced that it will release its third quarter 2025 results on Thursday, October 30, 2025 before market open and host a conference call to review the results at 8:30am ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US62855J1043
Myriad Genetics Inc
MYGN
LISTED
NASDAQ
Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel
News Preview
The Foresight® Carrier Screen includes all conditions recommended by the American College of Medical Genetics and Genomics recommendations The Foresight® Carrier Screen includes all conditions recommended by the American College of Medical Genetics and Genomics recommendations...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.10.2025
ISIN: US35104E1001
4D Molecular Therapeutics Inc
FDMT
LISTED
NASDAQ
4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference
News Preview
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will par...
Themefolio
Profiler
Peergroup
© Newsfile
14.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces New Franchise Agreement and Real Estate Secured for Heal Wellness in Airdrie, Alberta
News Preview
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada, is pleased to announce the signing of a new franchise agreement and secured real estate for Heal Wellness ("Heal") in Airdrie, Alberta...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
